Hormone Therapy

New guidance on primary prevention of stroke from the American Heart Association and American Stroke Association states women with endometriosis and early menopause are at higher risk, requiring a thorough history and tailored management.

Male patients in all age groups, especially those aged between 16 and 55 years, may face higher AKI risk than female patients, according to data that assessed the impact of sex and age on kidney health.

About one in four women experience vulvovaginal pain that persists for 3 to 6 months or more, yet many delay seeking care or struggle to find a physician who can provide effective treatment.

Patients with overweight or obesity assigned tirzepatide lost more weight compared with those assigned semaglutide, according to new results from the SURMOUNT-5 trial announced by Eli Lilly.

Women are living, on average, 5 years longer than men with an improved overall quality of life, but with an increased lifespan comes greater risk for multimorbidity, particularly after the menopause transition.

An AI model classified risk for prostate cancer metastasis more accurately than standard guidelines, suggesting the approach could be used to reduce overtreatment or undertreatment.

Cardiovascular disease risks vary depending on the type of menopausal hormone therapy combinations and administration methods used, according to a nationwide trial published in The BMJ.

Short-term exposure to hormone therapy started within 3 years of menopause was not associated with long-term cognitive impairment or benefit, according to data from the KEEPS Continuation study.

PHILADELPHIA — Although there was no overall increased risk for flare 1 year after gender-affirming hormone therapy in patients with inflammatory bowel disease, active IBD and receiving testosterone increased the likelihood of a flare.

One journal reviewer told Donald P. McDonnell, PhD, the research should be “banned from the literature.”